Expression of VEGF-C and activation of its receptors VEGFR-2 and VEGFR-3 in trophoblast

Histology and Histopathology

Volumn 16, Issue 2, 2001, Pages 359-375

  Dunk, C ^a   Ahmed, A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Endothelial cells; IUGR; Placenta; Pregnancy; VEGF C; VEGFR 2 (KDR)

Indexed keywords

ANGIOGENIC FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEOHEPARAN SULFATE; RECOMBINANT VASCULOTROPIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ARTICLE; BLOOD VESSEL PERMEABILITY; CELL ACTIVATION; CELL MIGRATION; CELL PROLIFERATION; DECIDUA; DNA SYNTHESIS; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; PANCREAS CARCINOMA; PLACENTA CIRCULATION; PLACENTA DEVELOPMENT; PLACENTA DISORDER; PLACENTA VILLUS; PRENATAL GROWTH; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SYNCYTIOTROPHOBLAST; THIRD TRIMESTER PREGNANCY; TROPHOBLAST; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, PANCREATIC DUCTAL; CULTURE MEDIA, CONDITIONED; ENDOMETRIUM; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; FETAL GROWTH RETARDATION; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; LYMPHOKINES; MATCHED-PAIR ANALYSIS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLACENTA; PREGNANCY; PREGNANCY PROTEINS; PROTEIN ISOFORMS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TROPHOBLASTS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3; VASCULAR ENDOTHELIAL GROWTH FACTORS;

MAMMALIA;

EID: 0035065893     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Hypoxia or hyperoxia in placental insufficiency
2. Colocalisation of vascular endothelial growth factor and its flt-1 receptor in human placenta
3. Role of VEGF Receptor (Flt-1) in mediating calcium dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells
4. Role of vascular endothelial growth factor (VEGF) in human extravillous trophoblast proliferation, migration and invasiveness
5. Differential expression of the two VEGF receptor flt and KDR in placenta and vascular endothelial cells
6. Localisation and activation of the receptor for vascular endothelial growth factor on human trophoblast and choriocarcinoma cells
7. Localisation of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy
8. The fms like tyrosine kinase a receptor for vascular endothelial growth factor
9. Fetal vasculogenesis and angiogenesis in human placental villi
10. Study of thromboxane and prostacyclin metabolism in an invitro model of first trimester trophoblast
11. Angiopoietin-1 and angiopoietin-2 are differentially expressed during placental development
12. Measurement of human fetal blood flow
13. The biology of vascular endothelial growth factor
14. Characterisation of the murine Flt-4 ligand/VEGF-C
15. The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor
16. 121 to one of the three vascular endothelial cell receptors of vascular endothelial cells
17. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH-2 domains. Association with endothelial cell proliferation
18. Pregnancy screening by doppler uteroplacental and umbilical artery waveforms
19. Doppler umbilical artery waveforms indices - Normal values from fourteen to forty two weeks
20. Normal human trophoblast express and respond to angiogenic growth factors
21. Localisation of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestation
22. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
23. Proteolytic processing regulates receptor specificity and activity of VEGF-C
24. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development
25. The regulation of AP-1 activity by mitogen activated protein kinases
26. The fetal vascularisation of term human placental villi. II. Intermediate and terminal villi
27. Inflammatory mediators and parturition
28. Identification of vascular endothelial growth factor determinants for binding KDR and Flt-1 receptors. Generation of receptor selective variants by site directed mutagenesis
29. The carboxy-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency
30. Hypoxia down regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: Molecular evidence for "Placental hyperoxia" in Intrauterine growth restriction
31. Oxygen and placental villous development: Origins of fetal hypoxia
32. Insulin-like growth factors: Their regulation of glucose and amino acid transport in placental trophoblast isolated from first trimester chorionic villi
33. Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree
34. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a rolel in lymphatic development
35. Regulation of chemotaxis by the platelet-derived growth factor receptor-beta
36. Placenta growth factor stimulates MAP kinase and mitogenecity but not phospholipase C-γ and migration of endothelial cells expressing Flt-1
37. The fetal vascularisation of term human placental villi. I. Peripheral stem villi
38. Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Dopplar waveforms
39. High affinity vascular endothelial growth factor binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
40. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chrioallantoic membrane
41. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells
42. Control of vascular endothelial growth factor angiogenic activity by the extracellular matrix
43. Venous drainage of the human uterus: Respiratory gas studies in normal and fetal growth retarded pregnancies
44. Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis
45. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C
46. Differential binding characteristics and cellular inhibition by soluble VEGF Receptors 1 and 2
47. Expression of mRNA for vascular endothelial growth factor in human placenta
48. Immunohistochemical localisation of vascular endothelial growth factor in the human placenta
49. Management of preeclampsia
50. Expression of the VEGF gene family during retinal vaso-obliteration and hypoxia
51. Vascular endothelial growth factor (VEGF): A putative initiator of labour
52. VEGF receptor subtypes KDR and Flt-1 show different sensitive to heparin and placenta growth factor
53. 165 with soluble and cell associated flk-1 receptors
54. Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic endothelial cells
55. Expression of the vascular endothelial growth factor receptor, KDR, in human placenta
56. Different signal transduction properties of KDR and FLT-1, two receptors for vascular endothelial growth factor